OTC DOXYLAMINE-CONTAINING ANTIHISTAMINES TO BE INCLUDED IN FINAL MONOGRAPH
This article was originally published in The Tan Sheet
Executive Summary
OTC DOXYLAMINE-CONTAINING ANTIHISTAMINES TO BE INCLUDED IN FINAL MONOGRAPH and will not require tumorigenicity label warnings, according to an amendment to the antihistamine monograph published by FDA in the Jan. 28 Federal Register. The amendment notice follows the recommendations of the Nonprescription Drugs Advisory Committee at a June 28 meeting ("The Tan Sheet" July 5, 1993, p. 5).